Sarah E Watts1, Adrienne Turnell1, Natalie Kladnitski1, Jill M Newby2, Gavin Andrews1. 1. Clinical Research Unit for Anxiety and Depression, Level 4 O'Brien Centre, 394-404 Victoria Street, St Vincent׳s Hospital, Darlinghurst, NSW, Australia. 2. Clinical Research Unit for Anxiety and Depression, Level 4 O'Brien Centre, 394-404 Victoria Street, St Vincent׳s Hospital, Darlinghurst, NSW, Australia. Electronic address: j.newby@unsw.edu.au.
Abstract
OBJECTIVES: There were three aims of this study, the first was to examine the efficacy of CBT versus treatment-as-usual (TAU) in the treatment of anxiety and depressive disorders, the second was to examine how TAU is defined in TAU control groups for those disorders, and the third was to explore whether the type of TAU condition influences the estimate of effects of CBT. METHOD: A systematic search of Cochrane Central Register of Controlled Trials, PsycINFO, and CINAHL was conducted. RESULTS: 48 studies of CBT for depressive or anxiety disorders (n=6926) that specified that their control group received TAU were identified. Most (n=45/48) provided an explanation of the TAU group however there was significant heterogeneity amongst TAU conditions. The meta-analysis showed medium effects favoring CBT over TAU for both anxiety (g=0.69, 95% CI 0.47-0.92, p<0.001, n=1318) and depression (g=0.70, 95% CI 0.49-0.90, p<0.001, n=5054), with differential effects observed across TAU conditions. CONCLUSIONS: CBT is superior to TAU and the size of the effect of CBT compared to TAU depends on the nature of the TAU condition. The term TAU is used in different ways and should be more precisely described. The four key details to be reported can be thought of as "who, what, how many, and any additional treatments?"
OBJECTIVES: There were three aims of this study, the first was to examine the efficacy of CBT versus treatment-as-usual (TAU) in the treatment of anxiety and depressive disorders, the second was to examine how TAU is defined in TAU control groups for those disorders, and the third was to explore whether the type of TAU condition influences the estimate of effects of CBT. METHOD: A systematic search of Cochrane Central Register of Controlled Trials, PsycINFO, and CINAHL was conducted. RESULTS: 48 studies of CBT for depressive or anxiety disorders (n=6926) that specified that their control group received TAU were identified. Most (n=45/48) provided an explanation of the TAU group however there was significant heterogeneity amongst TAU conditions. The meta-analysis showed medium effects favoring CBT over TAU for both anxiety (g=0.69, 95% CI 0.47-0.92, p<0.001, n=1318) and depression (g=0.70, 95% CI 0.49-0.90, p<0.001, n=5054), with differential effects observed across TAU conditions. CONCLUSIONS: CBT is superior to TAU and the size of the effect of CBT compared to TAU depends on the nature of the TAU condition. The term TAU is used in different ways and should be more precisely described. The four key details to be reported can be thought of as "who, what, how many, and any additional treatments?"
Authors: Bettina Sorger; Frank Scharnowski; David E J Linden; Michelle Hampson; Kymberly D Young Journal: Neuroimage Date: 2018-11-10 Impact factor: 6.556
Authors: Emily L Escovar; Michelle Craske; Peter Roy-Byrne; Murray B Stein; Greer Sullivan; Cathy D Sherbourne; Alexander Bystritsky; Denise A Chavira Journal: J Anxiety Disord Date: 2018-03-12
Authors: Barbara Resnick; N Jennifer Klinedinst; Laura Yerges-Armstrong; Jay Magaziner; Denise Orwig; Marc C Hochberg; Ann L Gruber-Baldini; Susan G Dorsey Journal: Int J Orthop Trauma Nurs Date: 2019-03-23
Authors: Saira A Weinzimmer; Amy R Goetz; Andrew G Guzick; Lynn M Hana; Sandra L Cepeda; Sophie C Schneider; Sarah M Kennedy; Gifty N Amos Nwankwo; Catherine C Christian; Ashley M Shaw; Alison Salloum; Asim A Shah; Wayne K Goodman; Jill Ehrenreich-May; Eric A Storch Journal: Community Ment Health J Date: 2022-04-04
Authors: Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson Journal: World Psychiatry Date: 2020-06 Impact factor: 49.548
Authors: Joseph K Carpenter; Leigh A Andrews; Sara M Witcraft; Mark B Powers; Jasper A J Smits; Stefan G Hofmann Journal: Depress Anxiety Date: 2018-02-16 Impact factor: 6.505